Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-Boc-L-tert-Leucine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

62965-35-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 62965-35-9 Structure
  • Basic information

    1. Product Name: N-Boc-L-tert-Leucine
    2. Synonyms: BOC-TBU-GLYCINE;BOC-TBU-GLY-OH;BOC-TLE;BOC-TLE-OH;BOC-ALPHA-BUTYLGLYCINE;BOC-ALPHA-T-BUTYLGLYCINE;BOC-ALPHA-T-BUTYLGLYCINE-OH;BOC-ALPHA-T-BUTYL-GLY-OH
    3. CAS NO:62965-35-9
    4. Molecular Formula: C11H21NO4
    5. Molecular Weight: 231.29
    6. EINECS: 1312995-182-4
    7. Product Categories: Amino Acids;Leucine [Leu, L];Amino Acids & Deriv.;CHIRAL CHEMICALS;Peptide
    8. Mol File: 62965-35-9.mol
  • Chemical Properties

    1. Melting Point: 118-121 °C
    2. Boiling Point: 350 °C at 760 mmHg
    3. Flash Point: 165.5 °C
    4. Appearance: White to slightly yellow/Crystalline Powder
    5. Density: 1.063 g/cm3
    6. Vapor Pressure: 7.8E-06mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: Store at RT.
    9. Solubility: DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
    10. BRN: 1962763
    11. CAS DataBase Reference: N-Boc-L-tert-Leucine(CAS DataBase Reference)
    12. NIST Chemistry Reference: N-Boc-L-tert-Leucine(62965-35-9)
    13. EPA Substance Registry System: N-Boc-L-tert-Leucine(62965-35-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: 24/25
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 62965-35-9(Hazardous Substances Data)

62965-35-9 Usage

Chemical Properties

White crystalline powder

Uses

Atazanavir Related Compound A

Check Digit Verification of cas no

The CAS Registry Mumber 62965-35-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,9,6 and 5 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 62965-35:
(7*6)+(6*2)+(5*9)+(4*6)+(3*5)+(2*3)+(1*5)=149
149 % 10 = 9
So 62965-35-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H21NO4/c1-10(2,3)7(8(13)14)12-9(15)16-11(4,5)6/h7H,1-6H3,(H,12,15)(H,13,14)/p-1/t7-/m1/s1

62965-35-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B3754)  N-(tert-Butoxycarbonyl)-L-tert-leucine  >98.0%(HPLC)(T)

  • 62965-35-9

  • 5g

  • 690.00CNY

  • Detail
  • TCI America

  • (B3754)  N-(tert-Butoxycarbonyl)-L-tert-leucine  >98.0%(HPLC)(T)

  • 62965-35-9

  • 25g

  • 2,490.00CNY

  • Detail
  • Alfa Aesar

  • (H51136)  N-Boc-L-tert-leucine, 98%   

  • 62965-35-9

  • 1g

  • 329.0CNY

  • Detail
  • Alfa Aesar

  • (H51136)  N-Boc-L-tert-leucine, 98%   

  • 62965-35-9

  • 5g

  • 1098.0CNY

  • Detail
  • Alfa Aesar

  • (H51136)  N-Boc-L-tert-leucine, 98%   

  • 62965-35-9

  • 25g

  • 3584.0CNY

  • Detail
  • Aldrich

  • (15451)  Boc-Tle-OH  ≥99.0% (T)

  • 62965-35-9

  • 15451-5G-F

  • 1,021.41CNY

  • Detail
  • Aldrich

  • (15451)  Boc-Tle-OH  ≥99.0% (T)

  • 62965-35-9

  • 15451-25G-F

  • 2,762.37CNY

  • Detail

62965-35-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Boc-L-tert-Leucine

1.2 Other means of identification

Product number -
Other names N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-valine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:62965-35-9 SDS

62965-35-9Synthetic route

L-tert-Leucine
20859-02-3

L-tert-Leucine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
With triethylamine In methanol at 0 - 5℃;100%
With triethylamine In methanol at 0 - 5℃;100%
With sodium hydroxide In 1,4-dioxane at 20℃; for 12h;100%
NaHSO4·H2O

NaHSO4·H2O

L-tert-Leucine
20859-02-3

L-tert-Leucine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water99%
With triethylamine In 1,4-dioxane; water99%
D,L-N-Boc-t-leucine methyl ester

D,L-N-Boc-t-leucine methyl ester

A

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

B

N-Boc-D-tert-leucine methyl ester
153960-35-1

N-Boc-D-tert-leucine methyl ester

Conditions
ConditionsYield
With Bacillus licheniformis In water at 35℃; for 23h; pH=7.8;A 93%
B n/a
With Bacillus licheniformis In water at 35℃; for 18h; pH=7.8;A n/a
B 82%
N-Boc-L-tert-leucinol
153645-26-2

N-Boc-L-tert-leucinol

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
With sodium hypochlorite; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; Isopropyl acetate; sodium hydrogencarbonate; sodium bromide at 0 - 25℃;73%
C14H21F6NO4

C14H21F6NO4

A

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

B

(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid
124655-17-0

(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid

Conditions
ConditionsYield
With C28H30N3O2(1+)*Br(1-); sodium hydroxide In chloroform at 0℃; for 24h;A 52%
B n/a
N-(tert-butyloxycarbonyl) azide
1070-19-5

N-(tert-butyloxycarbonyl) azide

L-tert-Leucine
20859-02-3

L-tert-Leucine

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane
L-tert-Leucine
20859-02-3

L-tert-Leucine

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile
58632-95-4

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water for 4h; Ambient temperature;
(4S,5R)-3-tert-butoxycarbonyl-4-tert-butyl-5-methoxy-2-oxazolidinone
335628-21-2

(4S,5R)-3-tert-butoxycarbonyl-4-tert-butyl-5-methoxy-2-oxazolidinone

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
With potassium hydroxide; potassium permanganate In water; tert-butyl alcohol
D,L-N-Boc-t-leucine methyl ester

D,L-N-Boc-t-leucine methyl ester

A

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

B

(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid
124655-17-0

(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid

C

N-Boc-D-tert-leucine methyl ester
153960-35-1

N-Boc-D-tert-leucine methyl ester

Conditions
ConditionsYield
With subtilisin In water at 35℃; for 18h; pH=7.5;
D,L-N-Boc-t-leucine methyl ester

D,L-N-Boc-t-leucine methyl ester

A

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

B

N-Boc-D-tert-leucine methyl ester
153960-35-1

N-Boc-D-tert-leucine methyl ester

C

2-tert-butoxycarbonylamino-3,3-dimethylbutyric acid methyl ester
176504-88-4

2-tert-butoxycarbonylamino-3,3-dimethylbutyric acid methyl ester

Conditions
ConditionsYield
With subtilisin In water at 35℃; for 15h; pH=7.5;
(4S,5R)-4-tert-butyl-5-methoxy-2-oxazolidinone
335627-81-1

(4S,5R)-4-tert-butyl-5-methoxy-2-oxazolidinone

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Et3N; DMAP / CH2Cl2 / 2 h / 20 °C
2: KMnO4; KOH / 2-methyl-propan-2-ol; H2O
View Scheme
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

tert-butylaminoacetic acid
58482-93-2

tert-butylaminoacetic acid

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
In tetrahydrofuran; sodium hydroxide
t-butoxycarbonyl-anhydride

t-butoxycarbonyl-anhydride

L-tert-Leucine
20859-02-3

L-tert-Leucine

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
With hydrogenchloride; sodium hydroxide In 1,4-dioxane; water; ethyl acetate
(S)-ethyl 3,3-dimethyl-2-[(S)-phenylmethanesulfinamido]butanoate
1203546-60-4

(S)-ethyl 3,3-dimethyl-2-[(S)-phenylmethanesulfinamido]butanoate

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride / methanol
2: triethylamine
3: lithium hydroxide / water
View Scheme
(E)-[(S)-2-methylpropane-2-sulfinylimino]acetic acid ethyl ester

(E)-[(S)-2-methylpropane-2-sulfinylimino]acetic acid ethyl ester

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: tetrahydrofuran / 12 h / -20 - 20 °C / Inert atmosphere
2: hydrogenchloride / methanol
3: triethylamine
4: lithium hydroxide / water
View Scheme
C13H25NO4
1465120-76-6

C13H25NO4

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
With lithium hydroxide In water
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

ethyl (S)-2-amino-3,3-dimethylbutanoate
69557-34-2

ethyl (S)-2-amino-3,3-dimethylbutanoate

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine
2: lithium hydroxide / water
View Scheme
(S)-ethyl 2-[butanesulfinamido]-3,3-dimethylbutanoate

(S)-ethyl 2-[butanesulfinamido]-3,3-dimethylbutanoate

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: thionyl chloride / methanol
2: triethylamine
3: lithium hydroxide / water
View Scheme
(R)-1-chloro-3,3-dimethyl-2-butanol
152488-38-5

(R)-1-chloro-3,3-dimethyl-2-butanol

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: di-isopropyl azodicarboxylate; triphenylphosphine / toluene / 15 h / -5 - 5 °C / Heating
2: hydrogenchloride; water / 15 h / Reflux
3: sodium hydroxide / water; ethanol / 40 - 50 °C
4: sodium hydrogencarbonate; sodium bromide; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; Isopropyl acetate; sodium hypochlorite / 0 - 25 °C
View Scheme
C10H16ClNO2

C10H16ClNO2

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride; water / 15 h / Reflux
2: sodium hydroxide / water; ethanol / 40 - 50 °C
3: sodium hydrogencarbonate; sodium bromide; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; Isopropyl acetate; sodium hypochlorite / 0 - 25 °C
View Scheme
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

(S)-tert-butyl (1-amino-3,3-dimethyl-1-oxobutan-2-yl)carbamate
372199-21-8

(S)-tert-butyl (1-amino-3,3-dimethyl-1-oxobutan-2-yl)carbamate

Conditions
ConditionsYield
With ammonium chloride; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 16h;100%
With 4-methyl-morpholine; ammonium chloride; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃;
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine With 4-methyl-morpholine; isobutyl chloroformate In tetrahydrofuran at -20℃; for 0.5h;
Stage #2: With ammonium hydroxide In tetrahydrofuran at -20 - 20℃;
With pyridine; di-tert-butyl dicarbonate; ammonium bicarbonate
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

L-4-hydroxyproline methyl ester hydrochloride
40216-83-9

L-4-hydroxyproline methyl ester hydrochloride

(2S,4R)-methyl 1-{(S)-2-[(tert-butoxycarbonyl)amino]-3,3-dimethylbutanoyl}-4-hydroxypyrrolidine-2-carboxylate
630421-45-3

(2S,4R)-methyl 1-{(S)-2-[(tert-butoxycarbonyl)amino]-3,3-dimethylbutanoyl}-4-hydroxypyrrolidine-2-carboxylate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 0 - 20℃;100%
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 0 - 20℃; for 16h;98%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 12h;92%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

benzyl bromide
100-39-0

benzyl bromide

(S)-benzyl 2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid
154092-61-2

(S)-benzyl 2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 72h;100%
With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 0 - 22℃; for 3.5h;98%
With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 0 - 20℃; for 3.08333h;93%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 72h;
4R-(7-methoxy-2-pyrazol-1-yl-quinolin-4-yloxy)-pyrrolidine-2S-carboxylic acid methyl ester hydrochloride
918662-07-4

4R-(7-methoxy-2-pyrazol-1-yl-quinolin-4-yloxy)-pyrrolidine-2S-carboxylic acid methyl ester hydrochloride

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

1-(2S-tert-butoxycarbonylamino-3,3-dimethylbutyryl)-4R-(7-methoxy-2-pyrazol-1-yl-quinolin-4-yloxy)-pyrrolidine-2S-carboxylic acid methyl ester
918662-09-6

1-(2S-tert-butoxycarbonylamino-3,3-dimethylbutyryl)-4R-(7-methoxy-2-pyrazol-1-yl-quinolin-4-yloxy)-pyrrolidine-2S-carboxylic acid methyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane; N,N-dimethyl-formamide at 20℃; for 16h;100%
4R-(5-chloropyridin-2-yloxy)-pyrrolidine-2S-carboxylic acid methyl ester hydrochloride salt

4R-(5-chloropyridin-2-yloxy)-pyrrolidine-2S-carboxylic acid methyl ester hydrochloride salt

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

1-(2S-tert-butoxycarbonylamino-3,3-dimethylbutyryl)-4R-(5-chloropyridin-2-yloxy)-pyrrolidine-2S-carboxylic acid methyl ester

1-(2S-tert-butoxycarbonylamino-3,3-dimethylbutyryl)-4R-(5-chloropyridin-2-yloxy)-pyrrolidine-2S-carboxylic acid methyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane; N,N-dimethyl-formamide at 20℃; for 16h;100%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

methyl iodide
74-88-4

methyl iodide

methyl (2S)-3,3-Dimethyl-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]butanoate
287210-99-5

methyl (2S)-3,3-Dimethyl-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]butanoate

Conditions
ConditionsYield
With silver(l) oxide In N,N-dimethyl-formamide at 45℃; Inert atmosphere;100%
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 0.5h; Inert atmosphere;
Stage #2: methyl iodide In N,N-dimethyl-formamide at 20℃; for 8h;
89%
With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃;
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

N,N-dimethylammonium chloride
506-59-2

N,N-dimethylammonium chloride

(S)-tert-butyl 1-(dimethylamino)-3,3-dimethyl-1-oxobutan-2-ylcarbamate
340161-34-4

(S)-tert-butyl 1-(dimethylamino)-3,3-dimethyl-1-oxobutan-2-ylcarbamate

Conditions
ConditionsYield
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine With HBTU In dichloromethane for 0.0333333h; Inert atmosphere;
Stage #2: N,N-dimethylammonium chloride With N-ethyl-N,N-diisopropylamine In dichloromethane for 1.5h; Inert atmosphere;
100%
With triethylamine; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h; Cooling with ice;91%
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 18h;
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; for 3h;
(R)-3-[(2S,3S)-2-amino-3-phenylbutyrylamino]-3-(thiazol-2-yl)propanoic acid methyl ester
66854-34-0

(R)-3-[(2S,3S)-2-amino-3-phenylbutyrylamino]-3-(thiazol-2-yl)propanoic acid methyl ester

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

N-{N'-tert-butoxycarbonyl-L-tert-leucyl-[(3S)-3-methyl-L-phenylalanyl]}-3-amino-3-(thiazol-2-yl)propanoic acid methyl ester
1138161-59-7

N-{N'-tert-butoxycarbonyl-L-tert-leucyl-[(3S)-3-methyl-L-phenylalanyl]}-3-amino-3-(thiazol-2-yl)propanoic acid methyl ester

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃;100%
With N-ethyl-N,N-diisopropylamine; O-(benzotriazol-1-yl)-N,N,N,N-tetramethyluroniumhexafluorophosphate In dichloromethane; N,N-dimethyl-formamide100%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

N-tert-butoxycarbonyl-L-tert-leucine 2-aminoanilide
1138161-53-1

N-tert-butoxycarbonyl-L-tert-leucine 2-aminoanilide

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃;100%
4-nitro-benzoic acid 5-(1-methoxycarbonyl-2-vinylcyclopropylcarbamoyl)pyrrolidin-3-yl ester hydrochloride

4-nitro-benzoic acid 5-(1-methoxycarbonyl-2-vinylcyclopropylcarbamoyl)pyrrolidin-3-yl ester hydrochloride

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

C30H40N4O10
1219511-19-9

C30H40N4O10

Conditions
ConditionsYield
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 20℃; for 0.166667h;
Stage #2: 4-nitro-benzoic acid 5-(1-methoxycarbonyl-2-vinylcyclopropylcarbamoyl)pyrrolidin-3-yl ester hydrochloride With N-ethyl-N,N-diisopropylamine In dichloromethane for 15h;
Stage #3: N-tert-butyloxycarbonyl-L-tert-leucine With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane for 5h;
100%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

(S)-methyl 3-(((R)-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylate

(S)-methyl 3-(((R)-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylate

(S)-methyl 2-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-3-(((R)-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylate

(S)-methyl 2-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-3-(((R)-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylate

Conditions
ConditionsYield
With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; Inert atmosphere;100%
With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃;
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

para-bromophenacyl bromide
99-73-0

para-bromophenacyl bromide

(S)-2-(4-bromophenyl)-2-oxoethyl 2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoate

(S)-2-(4-bromophenyl)-2-oxoethyl 2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 2h; Cooling with ice;100%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

benzyl alcohol
100-51-6

benzyl alcohol

(S)-benzyl 2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid
154092-61-2

(S)-benzyl 2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 12h;99%
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine With 2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile; triethylamine In 1,4-dioxane
Stage #2: benzyl alcohol With dmap; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 0℃;
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride at 0℃;
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

methylamine
74-89-5

methylamine

(S)-(2,2-dimethyl-1-methylcarbamoylpropyl)carbamic acid tert-butyl ester
200865-04-9

(S)-(2,2-dimethyl-1-methylcarbamoylpropyl)carbamic acid tert-butyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In DMF (N,N-dimethyl-formamide) at 0 - 20℃; for 4h;99%
Stage #1: methylamine With 1-hydroxy-pyrrolidine-2,5-dione In methanol; N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: N-tert-butyloxycarbonyl-L-tert-leucine With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In methanol; N,N-dimethyl-formamide at 0 - 20℃; for 3h;
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In chloroform at 23℃; for 18h; Inert atmosphere;
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; Inert atmosphere;
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

benzylamine
100-46-9

benzylamine

(S)-2-amino-N-benzyl-3,3-dimethylbutanamide
207121-91-3

(S)-2-amino-N-benzyl-3,3-dimethylbutanamide

Conditions
ConditionsYield
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine; benzylamine With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane for 1.5h;
Stage #2: With trifluoroacetic acid In dichloromethane at 20℃; for 1h; Further stages.;
99%
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine; benzylamine With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 23℃; for 2h;
Stage #2: With trifluoroacetic acid In dichloromethane at 23℃; for 1h; Further stages.;
98%
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 0.0333333h; Sealed tube;
Stage #2: benzylamine With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Sealed tube;
Stage #3: With trifluoroacetic acid In dichloromethane at 20℃; for 1h; Sealed tube;
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

(R)-4-hydroxy-L-proline ethyl ester
1499-56-5

(R)-4-hydroxy-L-proline ethyl ester

(2S,4R)-methyl 1-{(S)-2-[(tert-butoxycarbonyl)amino]-3,3-dimethylbutanoyl}-4-hydroxypyrrolidine-2-carboxylate
630421-45-3

(2S,4R)-methyl 1-{(S)-2-[(tert-butoxycarbonyl)amino]-3,3-dimethylbutanoyl}-4-hydroxypyrrolidine-2-carboxylate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 20℃; for 12h;99%
With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 0 - 20℃; for 12h;99%
With 4-methyl-morpholine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; tert-butyl alcohol In dichloromethane at 20℃;60%
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 0 - 20℃; for 18h;
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine With HATU In dichloromethane at 20℃; for 0.25h;
Stage #2: (R)-4-hydroxy-L-proline ethyl ester With N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; for 15h;
2-(1-ethoxycarbonyl-2-vinyl-cyclopropylcarbamoyl)-4-[2-(2-isopropylamino-thiazol-4-yl)-7-methoxy-quinolin-4-yloxy]-pyrrolidine-1-carboxylic acid tert-butyl ester
630424-24-7

2-(1-ethoxycarbonyl-2-vinyl-cyclopropylcarbamoyl)-4-[2-(2-isopropylamino-thiazol-4-yl)-7-methoxy-quinolin-4-yloxy]-pyrrolidine-1-carboxylic acid tert-butyl ester

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

BocNH-(L-t-BuGly)-[(4R)-[2-(2-isopropylaminothiazol-4-yl)-7-methoxyquinoline-4-oxo]-S-proline]-(1R,2S-vinyl acca)-COOEt
630424-25-8

BocNH-(L-t-BuGly)-[(4R)-[2-(2-isopropylaminothiazol-4-yl)-7-methoxyquinoline-4-oxo]-S-proline]-(1R,2S-vinyl acca)-COOEt

Conditions
ConditionsYield
Stage #1: 2-(1-ethoxycarbonyl-2-vinyl-cyclopropylcarbamoyl)-4-[2-(2-isopropylamino-thiazol-4-yl)-7-methoxy-quinolin-4-yloxy]-pyrrolidine-1-carboxylic acid tert-butyl ester With hydrogenchloride In 1,4-dioxane for 2.5h;
Stage #2: N-tert-butyloxycarbonyl-L-tert-leucine With 4-methyl-morpholine; HATU In DMF (N,N-dimethyl-formamide)
99%
Stage #1: 2-(1-ethoxycarbonyl-2-vinyl-cyclopropylcarbamoyl)-4-[2-(2-isopropylamino-thiazol-4-yl)-7-methoxy-quinolin-4-yloxy]-pyrrolidine-1-carboxylic acid tert-butyl ester With hydrogenchloride In 1,4-dioxane for 2.5h;
Stage #2: N-tert-butyloxycarbonyl-L-tert-leucine With 4-methyl-morpholine; HATU In N,N-dimethyl-formamide
99%
(2S,4R)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(7-methoxy-2-phenylquinolin-4-yloxy)pyrrolidine-2-carboxamide dihydrochloride

(2S,4R)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(7-methoxy-2-phenylquinolin-4-yloxy)pyrrolidine-2-carboxamide dihydrochloride

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

tert-butyl ((S)-1-((2S,4R)-2-(((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate
445304-34-7

tert-butyl ((S)-1-((2S,4R)-2-(((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate

Conditions
ConditionsYield
With 1-hydroxy-7-aza-benzotriazole; O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 16h; Product distribution / selectivity;99%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

N-(diphenylmethyl)methylamine
14683-47-7

N-(diphenylmethyl)methylamine

tert-butyl (S)-{1-[benzhydryl(methyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}carbamate
1200405-67-9

tert-butyl (S)-{1-[benzhydryl(methyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}carbamate

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 72h; Inert atmosphere;99%
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 72h;91%
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; Inert atmosphere;
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

(2S,4R)-4-hydroxy-N-{ [4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl}pyrrolidine-2-carboxamide hydrochloride
1448189-90-9

(2S,4R)-4-hydroxy-N-{ [4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl}pyrrolidine-2-carboxamide hydrochloride

tert‐butyl N‐[(2S)‐1‐[(2S,4R)‐4‐hydroxy‐2‐({[4‐(4‐methyl‐1,3‐thiazol‐5‐yl)phenyl]methyl}carbamoyl)pyrrolidin‐1‐yl]‐3,3‐dimethyl‐1‐oxobutan‐2‐yl]carbamate
1448189-98-7

tert‐butyl N‐[(2S)‐1‐[(2S,4R)‐4‐hydroxy‐2‐({[4‐(4‐methyl‐1,3‐thiazol‐5‐yl)phenyl]methyl}carbamoyl)pyrrolidin‐1‐yl]‐3,3‐dimethyl‐1‐oxobutan‐2‐yl]carbamate

Conditions
ConditionsYield
With triethylamine; HATU In N,N-dimethyl-formamide at 20℃; for 2h;99%
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 16h;84.46%
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 0 - 20℃; for 12h; Inert atmosphere;70%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

[(3R,5S)-5-[[4-[4-[[2-[2-(cyclopropylmethylamino)-4-pyridyl]oxazole-4-carbonyl]amino]-3-(difluoromethyl)pyrazol-1-yl]phenyl]methylcarbamoyl]pyrrolidin-3-yl]acetate

[(3R,5S)-5-[[4-[4-[[2-[2-(cyclopropylmethylamino)-4-pyridyl]oxazole-4-carbonyl]amino]-3-(difluoromethyl)pyrazol-1-yl]phenyl]methylcarbamoyl]pyrrolidin-3-yl]acetate

[(3R,5S)-1-[(2S)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoyl]-5-[[4-[4-[[2-[2-(cyclopropylmethylamino)-4-pyridyl]oxazole-4-carbonyl] amino]-3-(difluoromethyl)pyrazol-1-yl]phenyl]methylcarbamoyl]pyrrolidin-3-yl]acetate

[(3R,5S)-1-[(2S)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoyl]-5-[[4-[4-[[2-[2-(cyclopropylmethylamino)-4-pyridyl]oxazole-4-carbonyl] amino]-3-(difluoromethyl)pyrazol-1-yl]phenyl]methylcarbamoyl]pyrrolidin-3-yl]acetate

Conditions
ConditionsYield
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine; [(3R,5S)-5-[[4-[4-[[2-[2-(cyclopropylmethylamino)-4-pyridyl]oxazole-4-carbonyl]amino]-3-(difluoromethyl)pyrazol-1-yl]phenyl]methylcarbamoyl]pyrrolidin-3-yl]acetate With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: With N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 0.5h;
99%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

benzyl-methyl-amine
103-67-3

benzyl-methyl-amine

tert-butyl (S)-1-(N-benzyl-N-methylcarbamoyl)-2,2-dimethylpropylcarbamate
1032509-62-8

tert-butyl (S)-1-(N-benzyl-N-methylcarbamoyl)-2,2-dimethylpropylcarbamate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In chloroform at 23℃; for 18h; Inert atmosphere;98%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In chloroform at 23℃; for 18h; Inert atmosphere;98%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 18h;97%
C2HF3O2*C14H21N3O5S
630422-57-0

C2HF3O2*C14H21N3O5S

N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

BOC-NH-(L-tert-BuGly)-[(4R)-hydroxy-S-proline]-(1R,2S-vinyl acca)-CONHSO2-cyclopropane
630419-17-9

BOC-NH-(L-tert-BuGly)-[(4R)-hydroxy-S-proline]-(1R,2S-vinyl acca)-CONHSO2-cyclopropane

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 20℃; for 48h;98%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

(2S,4R)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide trifluoroacetic acid

(2S,4R)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide trifluoroacetic acid

tert‐butyl N‐[(2S)‐1‐[(2S,4R)‐4‐hydroxy‐2‐({[4‐(4‐methyl‐1,3‐thiazol‐5‐yl)phenyl]methyl}carbamoyl)pyrrolidin‐1‐yl]‐3,3‐dimethyl‐1‐oxobutan‐2‐yl]carbamate
1448189-98-7

tert‐butyl N‐[(2S)‐1‐[(2S,4R)‐4‐hydroxy‐2‐({[4‐(4‐methyl‐1,3‐thiazol‐5‐yl)phenyl]methyl}carbamoyl)pyrrolidin‐1‐yl]‐3,3‐dimethyl‐1‐oxobutan‐2‐yl]carbamate

Conditions
ConditionsYield
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine; (2S,4R)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide trifluoroacetic acid With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.0833333h;
Stage #2: With N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 0.5h;
98%
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 0.5h;98%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

(S)-7-nitro-N-((R)-1,2,3,4-tetrahydronaphthalen-1-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide

(S)-7-nitro-N-((R)-1,2,3,4-tetrahydronaphthalen-1-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide

tert-butyl ((S)-3,3-dimethyl-1-((S)-7-nitro-3-(((R)-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)-1-oxobutan-2-yl)carbamate

tert-butyl ((S)-3,3-dimethyl-1-((S)-7-nitro-3-(((R)-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)-1-oxobutan-2-yl)carbamate

Conditions
ConditionsYield
With 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;98%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

4-fluoro-2-methoxyaniline
450-91-9

4-fluoro-2-methoxyaniline

tert-butyl (S)-(1-((4-fluoro-2-methoxyphenyl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate

tert-butyl (S)-(1-((4-fluoro-2-methoxyphenyl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate

Conditions
ConditionsYield
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 0 - 20℃; for 12h; Inert atmosphere;98%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

isobutyl chloroformate
543-27-1

isobutyl chloroformate

(S)-tert-butyl (1-amino-3,3-dimethyl-1-oxobutan-2-yl)carbamate
372199-21-8

(S)-tert-butyl (1-amino-3,3-dimethyl-1-oxobutan-2-yl)carbamate

Conditions
ConditionsYield
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine; isobutyl chloroformate at 0℃; for 0.5h;
Stage #2: With ammonium hydroxide In water at 20℃; for 1.5h;
98%
N-tert-butyloxycarbonyl-L-tert-leucine
62965-35-9

N-tert-butyloxycarbonyl-L-tert-leucine

L-tert-Leucine
20859-02-3

L-tert-Leucine

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane97%
Stage #1: N-tert-butyloxycarbonyl-L-tert-leucine With methanesulfonic acid In dichloromethane at 25℃; for 3h;
Stage #2: With triethylamine In dichloromethane at 25℃; for 1h;
75%
With hydrogenchloride In water; toluene at 60℃; for 3h;

62965-35-9Downstream Products

62965-35-9Relevant articles and documents

Auxiliary-controlled diastereoselective synthesis of a syn C-6-epimer of the ADAM 10 inhibitor GI254023X

Nair, Shankari,Zeevaart, Jan Rijn,Hunter, Roger

, p. 90 - 102 (2020/10/08)

ADAM10 is a cell surface-expressed metalloprotease involved in various cell adhesion and proteolytic processes, in which biological studies have linked an over-expression of ADAM10 to the development and progression of various types of diseases including cancer. GI254023X is a hydroxamate metalloprotease inhibitor known for ADAM10 activity inhibition, but for which structure-activity based biological information for assessing anti-tumour and anti-inflammatory activity is lacking. In this work, an Evans’ asymmetric boron aldol reaction was used to synthesise a syn C-6-epimer of GI254023X intended for biological evaluation against the natural inhibitor.

Asymmetric Dearomative Cascade Multiple Functionalizations of Activated N-Alkylpyridinium and N-Alkylquinolinium Salts

Chen, Ying-Chun,Du, Wei,Song, Xue,Yan, Ru-Jie

supporting information, p. 7617 - 7621 (2020/10/09)

An enantioselective cascade reaction of N-alkylpyridinium and -quinolinium salts with o-hydroxybenzylideneacetones to access fused polyheterocycles through cross dienamine-mediated addition followed by trapping of the dearomatized enamine-type intermediates and aminal formation has been developed. A cascade assembly of N-benzyl-4-methylpyridinium salt and cyclic 2,4-dienones is further disclosed to give bridged frameworks via repetitive dearomatization and aromatization activation.

Novel 1,3,2-diazaphospholidines with pseudodipeptide substituents

Chuchelkin,Gavrilov,Firsin,Zimarev,Novikov,Maksimova,Shiryaev,Zheglov,Tafeenko,Chernyshev,Gavrilov

, p. 493 - 496 (2019/01/05)

Chiral 1,3,2-diazaphospholidine with pseudodipeptide substituents was prepared. This asymmetric inducer provided up to 84% ee in the Pd-catalyzed asymmetric allylic alkylation of (E)-1,3-diphenylallyl acetate with dimethyl malonate, and up to 53% ee in the Rh-catalyzed asymmetric hydrogenation of (Z)-methyl 2-acetamido-3-phenylacrylate.

A new type of L-Tertiary leucine-derived ligand: Synthesis and application in Cu(II)-catalyzed asymmetric Henry reactions

Cai, Zedong,Lan, Ting,Ma, Pengfei,Zhang, Jingfang,Yang, Qingqing,He, Wei

, (2019/08/08)

A new series of Schiff bases derived from amino acids were developed as chiral ligands for Cu(II)-catalyzed asymmetric Henry reactions. The optimum ligand 7d exhibited outstanding catalytic efficiency in the Cu(II)-catalyzed asymmetric Henry additions of four nitroalkanes to different kinds of aldehydes to produce 76 desired adducts in high yields (up to 96%) with excellent enantioselectivities, up to 99% enantiomeric excess (ee).

Highly enantioselective 1,3-dipolar cycloaddition of imino esters with benzofuranone derivatives catalyzed by thiourea?quaternary ammonium salt

Du, Ting,Li, Zhaokun,Zheng, Changwu,Fang, Guosheng,Yu, Longhui,Liu, Jun,Zhao, Gang

, p. 7485 - 7494 (2018/11/27)

Highly enantioselective 1, 3-dipolar cycloaddition of 2-arylidene-benzofuran- 3(2H)-ones with imino esters catalyzed by thiourea?quaternary ammonium salts has been developed. This reaction provides efficient construction of a range of chiral spiro[benzofuran-2,3′-pyrrolidine] in high yields (up to 99%) and with good enantioselectivities (up to 99% ee) under mild conditions.

Dynamic Kinetic Resolution of N-Protected Amino Acid Esters via Phase-Transfer Catalytic Base Hydrolysis

Yamamoto, Eiji,Wakafuji, Kodai,Furutachi, Yuho,Kobayashi, Kaoru,Kamachi, Takashi,Tokunaga, Makoto

, p. 5708 - 5713 (2018/05/30)

Asymmetric base hydrolysis of α-chiral esters with synthetic small-molecule catalysts is described. Quaternary ammonium salts derived from quinine were used as chiral phase-transfer catalysts to promote the base hydrolysis of N-protected amino acid hexafluoroisopropyl esters in a CHCl3/NaOH (aq) via dynamic kinetic resolution, providing the corresponding products in moderate to good yields (up to 99%) with up to 96:4 er. Experimental and computational mechanistic studies using DFT calculation and pseudotransition state (pseudo-TS) conformational search afforded a TS model accounting for the origin of the stereoselectivity. The model suggested π-stacking and H-bonding interactions play essential roles in stabilizing the TS structures.

Preparation method of N-alkoxy or benzyloxycarbonyl chiral amino acid

-

, (2018/03/24)

The invention provides a preparation method of N-alkoxy or benzyloxycarbonyl amino acid, particularly provides a preparation method of N-alkoxy or benzyloxycarbonyl chiral amino acid, and more particularly provides a preparation method of N-alkoxy or benzyloxycarbonyl-L-amino acid or N-alkoxy or benzyloxycarbonyl-D-amino acid. In the preparation method, a resolving agent is not required for chemical resolution, and the N-alkoxy or benzyloxycarbonyl chiral amino acid with high optical purity can be prepared. The N-alkoxy or benzyloxycarbonyl chiral amino acid is a very important medicine intermediate. According to the preparation method of the N-alkoxy or benzyloxycarbonyl-L-amino acid, provided by the invention, a reaction formula is as follows in the description, wherein R1 is an alkyl group, preferably a tert-butyl group; R2 is an azido group or an imide group, n is 0 or 1, and m is 1.

A chiral α - amino acid derivative and its preparation method (by machine translation)

-

Paragraph 0086; 0087, (2018/01/03)

The invention discloses a chiral α - amino acid derivative and its preparation method. The invention α - chiral amino acid derivatives, its structural formula shown in formula I: Its preparation method, comprises the following steps: with the carbonyl compound to the N, O - acetal of the mixture with a chiral primary uncle diamine organic small molecule catalyst, strong and weak acid mixing, reaction, to obtain the chiral α - amino acid compounds; the carbonyl compound including aldehyde and/or ketone. The invention chiral α - amino acid ester compound having a simple structure of the chiral primary uncle diamine organic small molecule catalyst catalytic, solvent-free, one-step synthesis, simple, high-efficiency. (by machine translation)

A Highly Active Polymer-Supported Catalyst for Asymmetric Robinson Annulations in Continuous Flow

Canellas, Santiago,Ayats, Carles,Henseler, Andrea H.,Pericàs, Miquel A.

, p. 1383 - 1391 (2017/08/09)

The preparation through Robinson annulation of enantiopure building blocks with both academic and industrial relevance, such as the Wieland-Miescher and Hajos-Parrish ketones, has suffered from important drawbacks, such as the need for high catalyst loading or extremely long reaction times. Here we report a heterogenized organocatalyst based on Luo's diamine for fast and broad-scope enantioselective Robinson annulation reactions. The polystyrene-supported diamine 19a enables the high-yield, highly enantioselective preparation of a wide range of chiral bicyclic enones under mild conditions, with reaction times as short as 60 min (batch) or residence times of 10 min (flow). In contrast with its homogeneous counterpart 19b, the catalytic resin 19a experiences a notable increase in catalytic activity with temperature in 2-MeTHF (a 10-fold decrease in reaction times without erosion in enantioselectivity is observed from room temperature to 55 °C). The scope of the transformation in batch mode has been illustrated with 14 examples, including examples only reported in poorly enantioenriched (22n) or in racemic form (22k). Enantiopure 22k has been used as the starting material for a straightforward formal synthesis of the antibiotic and antifeedant sesquiterpene (-)-isovelleral (24). The heterogenized catalyst 19a admits extended recycling (10 cycles) and has been used to develop the first asymmetric Robinson annulations in continuous flow. The potential of the flow process is illustrated by the large-scale preparation of the Wieland-Miescher ketone (65 mmol in 24 h of operation, TON of 117) and by a sequential flow experiment leading to a library of eight enantioenriched diketone compounds.

Chemo- and Diastereoselective N-Heterocyclic Carbene-Catalyzed Cross-Benzoin Reactions Using N-Boc-α-amino Aldehydes

Haghshenas, Pouyan,Gravel, Michel

supporting information, p. 4518 - 4521 (2016/09/28)

N-Boc-α-amino aldehydes are shown to be excellent partners in cross-benzoin reactions with aliphatic or heteroaromatic aldehydes. The chemoselectivity of the reaction and the facial selectivity on the amino aldehyde allow cross-benzoin products to be obtained in good yields and good diastereomeric ratios. The developed method is utilized as the key step in a concise total synthesis of d-arabino-phytosphingosine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 62965-35-9